How To Measure The Impact Of AI-Supported Mental Health Tools On Productivity, Retention And Cost

A CHRO can tell Finance that engagement is up. What Finance wants to know is whether that engagement moved the numbers it already tracks: output per employee, regretted attrition, and the medical spend line. That gap between "people are using it" and "here is what it returned" is where most digital mental health investments stall at renewal.

The market answering that gap increasingly includes AI-supported mental health tools, platforms that pair digital access with data infrastructure built to connect usage to business outcomes. This piece sets out what a defensible measurement model for that category actually looks like, and what evidence exists (and doesn't) to support it.

Most organizations already have a mental health benefit. The category norm for a traditional EAP is under 2% engagement, and a legacy EAP running at 2 to 4% utilisation is functioning as legal cover rather than care, since it exists to satisfy a duty-of-care requirement rather than to change outcomes at population scale. That's not a criticism of the people running it. It's a structural feature of a service network whose commercial model doesn't depend on engagement, so nobody inside it is incentivized to build the measurement layer a CHRO needs to defend the spend.

That's the pain underneath the question in this piece's title. CHROs and VPs of Benefits are being asked to identify pressure points, choose the right interventions, and prove impact to executives who want real-time reporting and benchmarks instead of an annual satisfaction survey. A tool that can't produce that reporting can't survive a budget review, however well it's used.

Before comparing any vendor's evidence, it helps to separate three different things that get bundled under "impact," because they require different data and different levels of proof.

Utilization is a leading indicator rather than an outcome. Knowing that 30% of a workforce logged in tells you adoption is happening, but it doesn't tell Finance whether anything changed, and a vendor that reports utilization alone is answering the easier question.

Productivity and retention, by contrast, are business metrics that already exist on someone else's dashboard. Absence rates, attrition, engagement scores, and manager-reported effectiveness are tracked whether or not a mental health tool exists, so the real measurement question is whether a platform can show its usage correlating with, or preceding, movement in those existing numbers, rather than whether it invents a new metric that only it reports.

Cost reduction is the hardest of the three to prove and the easiest to overstate. Claims about insurance claims reduction or healthcare cost savings require named, dated, third-party-auditable data, and in the absence of that kind of verified figure, the more honest and more useful frame is productivity impact translated into a dollar estimate, a measurable, study-based calculation rather than a claims-adjuster number.

The most useful evidence in this category comes from employers who measured before they talked to a vendor, not after, which is what makes it worth more than a case study written for a sales conversation. One employer gave staff access to Unmind for six months and tracked the result against real business outcomes rather than a satisfaction score: among the employees who started out most stressed, the study found a 16% reduction in stress and a 10% reduction in overall work impairment, translating to a projected 3.49x ROI and an estimated $1M impact from the recovered productivity. Another had been running a legacy EAP that almost nobody used, replaced it, and watched engagement move from a low single-digit rate to 43% within three months and 52% within six, inside the same workforce, with nothing else about the population changing in between. Neither company needs to be named for the numbers to hold up. What both share is a defined population, a before-and-after or control comparison, and a business metric Finance already recognizes, measured before the vendor conversation started rather than produced to support it. That's the bar a CHRO should hold any vendor's numbers to, including the numbers Unmind itself publishes.

Part of the CHRO's diligence question is what role AI is actually playing, because the term "AI therapy tools" gets used loosely across this category to describe everything from chatbots to clinical triage systems. It's worth being precise about what's inside that category and what isn't.

At Unmind, that capability is called Nova, an AI mental health agent. It gives employees quick, confidential support and connects them to human care, therapy, coaching, or the crisis line, when that's what's needed. Nova doesn't provide medical advice, diagnosis, assessment, or treatment, and it isn't a crisis or emergency intervention service. The therapy and coaching that show up in outcomes like the cases above are delivered by qualified human practitioners; AI's job in that pathway is matching and routing people to the right level of support faster, without replacing the clinical relationship. On the current benchmark, Nova users show 49% monthly retention against 39% for non-Nova users, evidence that the routing layer is keeping people in the system rather than a claim about clinical effectiveness.

The measurement implication: don't let a vendor's "AI-powered" framing distract from the underlying question, which is whether the platform as a whole (AI-assisted access plus human-delivered care) shows a connection to productivity, retention, and cost outcomes. AI adoption metrics are a useful proxy for how well the front door is working, not proof of business impact on their own.

A workable measurement approach for this category has four components, in the order a CFO is likely to ask about them.

Start with what's already broken. Pull current EAP utilisation, and if it's in the single digits, that's not a data point to soften, it's the opening argument: the incumbent benefit is invisible in the P&L because almost nobody uses it.

Insist on organizational-level analytics rather than individual login counts. The difference between reporting utilization and reporting impact is whether the platform can segment wellbeing and risk data by team, region, and business unit, and connect those trends to the metrics Finance already owns: absence, attrition, engagement. Insights & Assessments, the product Unmind built for this, does exactly that: it aggregates wellbeing data into dashboards showing stress signals and engagement patterns by team, and runs a diagnostic assessment of workforce psychosocial risk benchmarked against global standards, so a CHRO can point to where risk is concentrating before it shows up as a resignation or a leave claim.

Anchor the ROI conversation in a study rather than a projection. The stress-and-impairment study above shows what a credible calculation looks like: a defined population, a measured stress and work-impairment change, and an ROI figure derived from that measured change rather than assumed from industry averages.

Treat retention as a lagging confirmation rather than the headline metric, since mental health score improvements and reduced long-term leave take years to show up cleanly in any dataset. Use them to validate the model over time rather than to sell the first year.

None of this requires accepting a vendor's number at face value. It requires asking the same question of every vendor in the shortlist: whose study is this, what was the population, and what business metric moved. A platform built to consolidate a fragmented mental health stack into one contract and one data layer, rather than adding another point solution on top of an existing EAP, is also the one structurally positioned to answer that question consistently, because the measurement infrastructure has to exist before the consolidation argument does.

The comparison a CHRO is actually running in 2026 isn't AI platform versus AI platform. It's a renewal decision: keep funding an EAP line that can't produce the reporting Finance is asking for, or replace it with a platform built as one system from the start, Nova for AI-assisted access and routing, human-delivered therapy and coaching, manager training, and Insights & Assessments for the organizational data layer. The utilisation gap between the two isn't a marginal difference. It's the difference between a benefit that exists on paper and one that shows up in the numbers Finance already tracks.

For a broader framework on connecting any wellbeing program's spend to retention and turnover cost, including a vendor evaluation checklist, see our measurement-first guide to EAP impact on retention. For the case that mental health belongs on the same KPI dashboard as any other workforce metric, see the metrics every CHRO should track for wellbeing ROI. Neither covers the AI-specific measurement question this piece answers; both are useful for building the surrounding business case.

To see the organizational analytics and benchmarking layer described above, visit Insights & Assessments. To understand what Nova does, and doesn't, do inside that system, visit the Nova product page.